Vaillant MT - Search Results

1

The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data.

WorldWide Antimalarial Resistance Network (WWARN) AS-AQ Study Group; Adjuik MA, Allan R, Anvikar AR, Ashley EA, Ba MS, Barennes H, Barnes KI, Bassat Q, Baudin E, Björkman A, Bompart F, Bonnet M, Borrmann S, Brasseur P, Bukirwa H, Checchi F, Cot M, Dahal P, D'Alessandro U, Deloron P, Desai M, Diap G, Djimde AA, Dorsey G, Doumbo OK, Espié E, Etard JF, Fanello CI, Faucher JF, Faye B, Flegg JA, Gaye O, Gething PW, González R, Grandesso F, Guerin PJ, Guthmann JP, Hamour S, Hasugian AR, Hay SI, Humphreys GS, Jullien V, Juma E, Kamya MR, Karema C, Kiechel JR, Kremsner PG, Krishna S, Lameyre V, Ibrahim LM, Lee SJ, Lell B, Mårtensson A, Massougbodji A, Menan H, Ménard D, Menéndez C, Meremikwu M, Moreira C, Nabasumba C, Nambozi M, Ndiaye JL, Nikiema F, Nsanzabana C, Ntoumi F, Ogutu BR, Olliaro P, Osorio L, Ouédraogo JB, Penali LK, Pene M, Pinoges L, Piola P, Price RN, Roper C, Rosenthal PJ, Rwagacondo CE, Same-Ekobo A, Schramm B, Seck A, Sharma B, Sibley CH, Sinou V, Sirima SB, Smith JJ, Smithuis F, Somé FA, Sow D, Staedke SG, Stepniewska K, Swarthout TD, Sylla K, Talisuna AO, Tarning J, Taylor WR, Temu EA, Thwing JI, Tjitra E, Tine RC, Tinto H, Vaillant MT, Valecha N, Van den Broek … See abstract for full author list ➔ WorldWide Antimalarial Resistance Network (WWARN) AS-AQ Study Group, et al. Among authors: vaillant mt. BMC Med. 2015 Mar 31;13:66. doi: 10.1186/s12916-015-0301-z. BMC Med. 2015. PMID: 25888957 Free PMC article.

2

Therapeutic efficacy of clindamycin in combination with quinine for treating uncomplicated malaria in a village dispensary in Gabon.

Vaillant M, Millet P, Luty A, Tshopamba P, Lekoulou F, Mayombo J, Georges AJ, Deloron P. Vaillant M, et al. Trop Med Int Health. 1997 Sep;2(9):917-9. doi: 10.1046/j.1365-3156.1997.d01-411.x. Trop Med Int Health. 1997. PMID: 9315051 Free article. Clinical Trial.

3

Plasmodium falciparum in vitro susceptibility to antimalarial drugs in Casamance (southwestern Senegal) during the first 5 years of routine use of artesunate-amodiaquine.

Agnamey P, Brasseur P, de Pecoulas PE, Vaillant M, Olliaro P. Agnamey P, et al. Antimicrob Agents Chemother. 2006 Apr;50(4):1531-4. doi: 10.1128/AAC.50.4.1531-1534.2006. Antimicrob Agents Chemother. 2006. PMID: 16569876 Free PMC article.

4

Efficacy and safety of artesunate plus amodiaquine in routine use for the treatment of uncomplicated malaria in Casamance, southern Sénégal.

Brasseur P, Agnamey P, Gaye O, Vaillant M, Taylor WR, Olliaro PL. Brasseur P, et al. Malar J. 2007 Nov 15;6:150. doi: 10.1186/1475-2875-6-150. Malar J. 2007. PMID: 18005408 Free PMC article.

5

Geometric least squares means ratios for the analysis of Plasmodium falciparum in vitro susceptibility to antimalarial drugs.

Vaillant M, Olliaro P. Vaillant M, et al. Malar J. 2007 Nov 26;6:156. doi: 10.1186/1475-2875-6-156. Malar J. 2007. PMID: 18039388 Free PMC article.

6

Risk associated with asymptomatic parasitaemia occurring post-antimalarial treatment.

Olliaro P, Pinoges L, Checchi F, Vaillant M, Guthmann JP. Olliaro P, et al. Trop Med Int Health. 2008 Jan;13(1):83-90. doi: 10.1111/j.1365-3156.2007.01977.x. Trop Med Int Health. 2008. PMID: 18291006 Free article.

7

Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal.

Olliaro PL, Delenne H, Cisse M, Badiane M, Olliaro A, Vaillant M, Brasseur P. Olliaro PL, et al. Malar J. 2008 Nov 7;7:234. doi: 10.1186/1475-2875-7-234. Malar J. 2008. PMID: 18992140 Free PMC article.

8

Dosing accuracy of artesunate and amodiaquine as treatment for falciparum malaria in Casamance, Senegal.

Brasseur P, Agnamey P, Gaye O, Cisse M, Badiane M, Vaillant M, Taylor WR, Olliaro P. Brasseur P, et al. Trop Med Int Health. 2009 Jan;14(1):79-87. doi: 10.1111/j.1365-3156.2008.02190.x. Epub 2008 Nov 14. Trop Med Int Health. 2009. PMID: 19021893 Free article. Clinical Trial.

9

Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers.

Navaratnam V, Ramanathan S, Wahab MS, Siew Hua G, Mansor SM, Kiechel JR, Vaillant M, Taylor WR, Olliaro P. Navaratnam V, et al. Eur J Clin Pharmacol. 2009 Aug;65(8):809-21. doi: 10.1007/s00228-009-0656-1. Epub 2009 Apr 30. Eur J Clin Pharmacol. 2009. PMID: 19404632 Free PMC article. Clinical Trial.

10

New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine.

Krudsood S, Looareesuwan S, Tangpukdee N, Wilairatana P, Phumratanaprapin W, Leowattana W, Chalermrut K, Ramanathan S, Navaratnam V, Olliaro P, Vaillant M, Kiechel JR, Taylor WR. Krudsood S, et al. Antimicrob Agents Chemother. 2010 Sep;54(9):3730-7. doi: 10.1128/AAC.01187-09. Epub 2010 Jun 14. Antimicrob Agents Chemother. 2010. PMID: 20547795 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page